SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-17-011539
Filing Date
2017-12-22
Accepted
2017-12-22 17:11:21
Documents
18

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1652038
2 filename2.htm EX-10 111955
3 filename3.htm EX-21 1555
4 g475892g07q36.jpg GRAPHIC 58587
5 g475892g14y95.jpg GRAPHIC 68176
6 g475892g16k55.jpg GRAPHIC 77969
7 g475892g16r29.jpg GRAPHIC 119380
8 g475892g16s95.jpg GRAPHIC 115059
9 g475892g21d19.jpg GRAPHIC 99976
10 g475892g74c97.jpg GRAPHIC 60787
11 g475892g77j27.jpg GRAPHIC 60355
12 g475892g79t13.jpg GRAPHIC 76946
13 g475892g80i74.jpg GRAPHIC 62158
14 g475892g80m33.jpg GRAPHIC 43816
15 g475892g99k81.jpg GRAPHIC 80747
16 g47705201.jpg GRAPHIC 5866
17 g47705203.jpg GRAPHIC 13492
18 g47705204.jpg GRAPHIC 99551
  Complete submission text file 0000950123-17-011539.txt   3203854
Mailing Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01761 | Film No.: 171273275
SIC: 2834 Pharmaceutical Preparations